KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,811,599 | -18.9% | 856,535 | -5.9% | 2.20% | -34.7% |
| Q2 2023 | $9,631,154 | +120.4% | 910,317 | +154.8% | 3.36% | +133.3% |
| Q1 2023 | $4,369,620 | +31.0% | 357,287 | +32.9% | 1.44% | +10.2% |
| Q4 2022 | $3,335,150 | -65.8% | 268,747 | -62.3% | 1.31% | -51.9% |
| Q3 2022 | $9,738,000 | -42.8% | 712,853 | -23.2% | 2.72% | -62.1% |
| Q2 2022 | $17,015,000 | +14.5% | 928,256 | +0.4% | 7.17% | +201.7% |
| Q1 2022 | $14,860,000 | +89.5% | 924,147 | +65.0% | 2.38% | -16.5% |
| Q4 2021 | $7,840,000 | -21.0% | 560,000 | +5.7% | 2.85% | +13.6% |
| Q3 2021 | $9,927,000 | +12.0% | 530,000 | +24.7% | 2.51% | -21.0% |
| Q2 2021 | $8,861,000 | -14.1% | 425,000 | +16.4% | 3.17% | -9.5% |
| Q1 2021 | $10,319,000 | +21.5% | 365,000 | +40.4% | 3.50% | -22.2% |
| Q4 2020 | $8,492,000 | – | 260,000 | – | 4.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |